Be sure to check our sister interview main ratings news website

Arix Bioscience a diversified portfolio and an IRR of 20% since inception (Analyst Interview)

Arix Bioscience plc (LON:ARIX) is the topic of conversation when Dr Martin Hall, Analyst at Hardman & Co joins DirectorsTalk. Martin explains how Arix differs from other investment vehicles, how it has performed well since it released its interim results, trading relative to the NAV, narrowing the discount, the risks involved and what to expect from the company looking forward.

Questions we ask Dr Martin Hall:

Q1: Can you tell us what Arix does and how it differs from other investment vehicles?
Q2: The shares of Arix Bioscience have performed well since it released its interim results for 2020. Can you say what has been behind this movement?
Q3: So, how are the shares trading relative to the NAV?
Q4: What do you think will make this discount narrow?
Q5: What are the risks?
Q6: What is coming up in the near future?

Arix Bioscience is a United Kingdom-based healthcare and life science company. The Company is a holding company that is focused on generating value from the development and commercialization of technologies and discoveries.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Hardman & Co

    More articles like this

    Quadrise plc

    The maritime industry’s journey towards sustainability

    19th April 2024

    The international maritime industry plays a vital role in global trade, transporting over 90% of the world’s goods. However, this essential service comes at an environmental cost. Air and water pollution from ship operations pose significant

    Team Internet plc

    Navigating Domain disputes

    19th April 2024

    Domain disputes can be a long and painful process. Depending on the risk that is being posed or the damage that is being caused by the abusive registration, there are a number of different actions that

    Alkemy Capital Investments plc

    The importance of Mining in the Energy Transition

    19th April 2024

    Many years ago, there was a TV advertisement shot in the kitchen of a family home. All was well until the oven disappeared, then the refrigerator and the kettle. Then the cutlery from the table vanished

    ZoteFoams

    Zotefoams publishes 2023 Annual Report

    19th April 2024

    Zotefoams plc (LON:ZTF) has published its 2023 Annual Report and the Notice of the 2024 Annual General Meeting to be held at 675 Mitcham Road, Croydon CR9 3AL on 22 May 2024 at 10.00 a.m. Annex A

    Enteq Technologies plc

    Understanding Methane Capture

    18th April 2024

    Since the advent of the industrial revolution, man has continued to explore distinct ways of fulfilling energy needs. One of these techniques heavily relied upon is the extraction and burning of fossil fuels, an activity largely

    © 2023 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.